The Future of Bronchiectasis: AI, Machine Learning, and Lessons from IPF

Bronchiectasis is having a moment in pulmonary medicine. After many years of research and patient data, our understanding of bronchiectasis has finally reached a point where the future of bronchiectasis treatment is ready to be considered.

In this episode, rare lung disease expert Dr. Marion Wencker joins host Elizabeth Estes to explain why bronchiectasis finds itself in a similar position to where idiopathic pulmonary fibrosis (IPF) was 10 years ago. What lessons can the pulmonology community learn from its experience treating IPF? How will those insights, AI, and emerging therapies shape the future of treating bronchiectasis?

Listen to the conversation on The Lung Lab podcast, brought to you by the Open Source Imaging Consortium (OSIC), a show that explores how we are redefining rare and progressive lung disease. 

For more information on the Open Source Imaging Consortium (OSIC), visit https://osicild.org.